Ads
related to: Latest Treatment Copd- Sign Up For Updates
Receive The Latest Updates For This
COPD Maintenance Option.
- Savings Card Offer
Review Eligibility & Access Terms
For Your Patients.
- COPD Treatment Option
Explore Clinical Study Data To
Learn More About This Option.
- Administration Info
Physicians: Review Important
Dosing & Admin Information.
- Sampling Made Simple
Visit The Site To Learn How You Can
Request Samples.
- Physician Resources
Access Useful Resources For You &
Your COPD Patients.
- Sign Up For Updates
Search results
Earnings call: Verona Pharma reports Q1 2024 results, eyes COPD market By Investing.com
Investing.com· 22 hours agoVerona Pharma (NASDAQ:VRNA) has announced its first quarter 2024 financial results, highlighting the...
Insmed Incorporated (NASDAQ:INSM) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 hours agoInsmed Incorporated (NASDAQ:INSM) Q1 2024 Earnings Call Transcript May 9, 2024 Insmed Incorporated...
Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update - Verona...
Benzinga· 1 day agoPDUFA Target Action Date for Ensifentrine of June 26, 2024 Finalizing commercial launch preparations Strong balance sheet supports commercialization and pipeline expansion Conference call today at 9:00 a.m. EDT /
Varenicline Leads in Helping Smokers Kick the Habit, Study
Medscape· 2 days agoMost smokers do successfully quit after their first attempt. Switching patients from nicotine...
How Environmental Racism Continues to Burden the Health of Underserved Communities
Health.com· 7 days agoEnvironmental racism is a form of systemic racism that occurs when Black, Indigenous, and other...
Theravance Biopharma to Participate in an Upcoming Investor Conference
FOX21 Colorado Springs· 2 days agoTheravance Biopharma, Inc. (NASDAQ: TBPH) will participate in a Fireside Chat at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ Monday, May 20 at 11:30 AM EDT (8:30 ...
Smoking on oxygen killed 3 York countians this year. A $4.45 device might have saved them
Hanover Evening Sun via Yahoo News· 3 days ago"Typically, but not all the time, people who are on supplemental oxygen have a respiratory problem,...
The Interplay: Key Decisions at the Intersection of Antitrust & Life Sciences - April 2024 | JD...
JD Supra· 4 days agoThis week, the FTC continued its intense regulatory focus on pharmaceutical patents listed in the FDA’s Orange Book. As reported in earlier editions of The Interplay, the FTC issued a policy ...
ASLAN Pharmaceuticals to Present Additional Data From Interim Analysis of TREK-DX Phase 2 Study of...
Benzinga· 3 days agoASLAN Pharmaceuticals ASLN, a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, will today ...
Viemed Healthcare (VMD) to Release Earnings on Tuesday
ETF DAILY NEWS· 5 days agoViemed Healthcare (NASDAQ:VMD – Get Free Report) is scheduled to announce its earnings results before the market opens on Tuesday, May 7th. Viemed Healthcare has set its Q1 2024 guidance at ...
